A promising TB vaccine can be protected from heat damage with a technique developed at the University of Bath.
Scientists working on a new tuberculosis (TB) vaccine have achieved a major step forward by showing that a promising TB antigen and a novel vaccine adjuvant can be protected from heat damage with a technique developed at the University of Bath.
Their method prevents these crucial vaccine components from spoiling outside of a fridge – meaning a thermally stable vaccine that can be reliably delivered to remote areas around the world is more likely.
There is an urgent need not only for a new TB vaccine, but also for methods to keep vaccines stable outside of the refrigeration ‘cold chain’ – as up to 50% of vaccine doses are discarded before use due to exposure to suboptimal temperatures. Thermostable vaccines have therefore been named a priority research area in the World Health Organisation’s Global Vaccine Action Plan 2011-2020.
Ensilication, a method developed at the University of Bath, “shrink-wraps” vaccine proteins in position using layers of silica that build up into a cage around the molecules – so they don’t unravel when exposed to temperatures that would usually break them down. The proteins are held in place until ready to be removed from the silica cage and delivered.
The research team from the Departments of Biology & Biochemistry and Chemistry first demonstrated that the TB antigen ag85b and a vaccine fused with the adjuvant protein Sbi are sensitive to breaking down outside of refrigerated temperatures. They then showed that these vaccine components were protected from heat damage when ensilicated and kept on a shelf at room temperature for long periods of time without loss of structure and function.
This is first time that ensilication has been used to improve the thermal stability of proteins in a vaccine setting, after proof-of-principle work using model proteins.
The results are a big step forward not only in developing a thermally-stable TB vaccines, but in showing that ensilication could be used for many different kinds of vaccines.
The study is published in Scientific Reports
Lead author Professor Jean van den Elsen, said: “A new TB vaccine is really urgently needed to supplement or replace the existing BCG vaccine and reduce the number of TB cases and deaths – particularly as drug-resistant TB infections remain high.”
First author Ayla Wahid, added: “To make the vaccine as effective as possible it needs to be thermally-stable, or in other words not spoil outside of a fridge, which is why we’re really encouraged by these results. Cold-chain storage leads to a lot of wastage and expense which could be avoided by ensilication.”
Dr Asel Sartbaeva, who invented ensilication, added: “Our results reveal the potential of ensilication in storing and transporting life-saving vaccines at ambient temperatures globally – in particular to remote areas of developing countries where disease rates are often highest.
“With up to 50% of vaccines being thrown away, and refrigeration raising vaccine costs by up to 80%, this is a major global health challenge that we need to overcome. By demonstrating for the first time that ensilication works to protect vaccine-relevant proteins from breaking down outside a fridge we’re a big step closer to achieving this goal.”
Learn more: Thermally-stable TB vaccine closer to reality thanks to microscopic silica cages
The Latest on: TB vaccine
[google_news title=”” keyword=”TB vaccine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: TB vaccine
- BCG vaccines launched for adults in Andhraon May 18, 2024 at 3:36 am
According to state health officials, the anti-tuberculosis vaccination drive aims at reducing the number of cases, thereby ultimately eliminate TB cases in AP by 2025. The programme will be ...
- Home-grown vaccine demonstrates 100% protection against tuberculosison May 17, 2024 at 1:07 am
The Walter Sisulu and North-West universities unveiled the results of their preclinical trials for the combination vaccine against tuberculosis and COVID-19.
- Ministry licenses vaccines against dengue, shingles and pneumococcal 23on May 16, 2024 at 6:51 pm
Three new vaccines including a dengue fever vaccine, a vaccine against shingles and a pneumococcal 23 vaccine have been licensed by the Ministry of Health (MoH).
- Three-month anti-TB vaccination drive begins in 12 districtson May 16, 2024 at 7:26 am
Three-month anti-tuberculosis vaccination drive for individuals aged 18+ in 12 districts in State, starting May 16.
- TB vaccination programme at 508 centres in Krishna district from todayon May 15, 2024 at 10:28 pm
VIJAYAWADA: As a part of the programme to completely eliminate tuberculosis (TB) disease by 2025 in the State, District Medical and Health Officer Dr G Geetha Bai has conducted an awareness programme ...
- Opinion: UNGA should address TB and antimicrobial resistance togetheron May 15, 2024 at 8:33 am
Drug-resistant tuberculosis, which is spread through air and responsible for a large number of deaths, is part of antimicrobial resistance efforts. The United Nations General Assembly can pave the way ...
- Global TB Vaccine Trial Launches in Gqeberha to Address SA's Number One Killer Diseaseon May 15, 2024 at 2:10 am
The Wits Health Consortium announced the start of the Bill & Melinda Gates Medical Research Institute's (Gates MRI) large Phase 3 clinical trial to assess the efficacy of the M72/AS01E TB vaccine ...
- TB vaccination campaign for high-risk residents kicked off in five Delhi districtson May 14, 2024 at 10:26 pm
The Delhi health department launched the campaign at Jag Pravesh Chandra Hospital in the northeast district on Tuesday, where a TB survivor was among the six persons who were administered the vaccine.
- TB vaccine trial launched in Gqeberhaon May 14, 2024 at 5:00 pm
The trial will test the efficacy of the M72/AS01E tuberculosis (TB) vaccine candidate, and this initiative is deemed especially vital, given that the Eastern Cape has the highest incidence of TB in ...
- Vaccines: lies, damned lies, and statisticson May 14, 2024 at 3:36 pm
This week in Health Matters newsletter: the Covishield vaccine story, all about the new FLiRT variants, ICMR’s dietary guidelines and whether bird flu has the potential to turn into the next pandemic.
via Bing News